nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP1A2—Pentoxifylline—systemic scleroderma	0.145	0.254	CbGbCtD
Moclobemide—CYP1A2—Leflunomide—systemic scleroderma	0.138	0.242	CbGbCtD
Moclobemide—CYP2C9—Leflunomide—systemic scleroderma	0.125	0.218	CbGbCtD
Moclobemide—CYP2D6—Captopril—systemic scleroderma	0.0894	0.156	CbGbCtD
Moclobemide—CYP2C19—Prednisone—systemic scleroderma	0.074	0.13	CbGbCtD
Moclobemide—CYP2C9—cardial valve—systemic scleroderma	0.0172	0.585	CbGeAlD
Moclobemide—MAOB—connective tissue—systemic scleroderma	0.00152	0.0518	CbGeAlD
Moclobemide—MAOA—connective tissue—systemic scleroderma	0.0013	0.0442	CbGeAlD
Moclobemide—MAOB—digestive system—systemic scleroderma	0.0011	0.0374	CbGeAlD
Moclobemide—MAOB—tendon—systemic scleroderma	0.00105	0.0356	CbGeAlD
Moclobemide—CYP2C19—digestive system—systemic scleroderma	0.000959	0.0326	CbGeAlD
Moclobemide—MAOA—digestive system—systemic scleroderma	0.000939	0.0319	CbGeAlD
Moclobemide—MAOB—lung—systemic scleroderma	0.000919	0.0313	CbGeAlD
Moclobemide—MAOA—tendon—systemic scleroderma	0.000893	0.0304	CbGeAlD
Moclobemide—MAOA—lung—systemic scleroderma	0.000784	0.0267	CbGeAlD
Moclobemide—CYP1A2—digestive system—systemic scleroderma	0.000783	0.0267	CbGeAlD
Moclobemide—Chest pain—Mycophenolic acid—systemic scleroderma	0.000771	0.00193	CcSEcCtD
Moclobemide—Vision blurred—Lisinopril—systemic scleroderma	0.000768	0.00192	CcSEcCtD
Moclobemide—Gastrointestinal pain—Captopril—systemic scleroderma	0.000768	0.00192	CcSEcCtD
Moclobemide—Anxiety—Mycophenolic acid—systemic scleroderma	0.000768	0.00192	CcSEcCtD
Moclobemide—Asthenia—Mometasone—systemic scleroderma	0.000768	0.00192	CcSEcCtD
Moclobemide—Irritability—Prednisone—systemic scleroderma	0.000767	0.00192	CcSEcCtD
Moclobemide—Hypotension—Azathioprine—systemic scleroderma	0.000766	0.00192	CcSEcCtD
Moclobemide—Polyuria—Methotrexate—systemic scleroderma	0.000765	0.00192	CcSEcCtD
Moclobemide—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000765	0.00192	CcSEcCtD
Moclobemide—Tremor—Lisinopril—systemic scleroderma	0.000764	0.00191	CcSEcCtD
Moclobemide—Discomfort—Mycophenolic acid—systemic scleroderma	0.000761	0.00191	CcSEcCtD
Moclobemide—Pruritus—Mometasone—systemic scleroderma	0.000757	0.0019	CcSEcCtD
Moclobemide—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000756	0.00189	CcSEcCtD
Moclobemide—Tachycardia—Leflunomide—systemic scleroderma	0.000756	0.00189	CcSEcCtD
Moclobemide—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000754	0.00189	CcSEcCtD
Moclobemide—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000749	0.00188	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000747	0.00187	CcSEcCtD
Moclobemide—Confusional state—Mycophenolic acid—systemic scleroderma	0.000745	0.00187	CcSEcCtD
Moclobemide—CYP2C9—digestive system—systemic scleroderma	0.000743	0.0253	CbGeAlD
Moclobemide—Abdominal pain—Captopril—systemic scleroderma	0.000743	0.00186	CcSEcCtD
Moclobemide—Dry skin—Prednisone—systemic scleroderma	0.000737	0.00185	CcSEcCtD
Moclobemide—Nausea—Pentoxifylline—systemic scleroderma	0.000736	0.00184	CcSEcCtD
Moclobemide—Malaise—Lisinopril—systemic scleroderma	0.000735	0.00184	CcSEcCtD
Moclobemide—Diarrhoea—Mometasone—systemic scleroderma	0.000732	0.00183	CcSEcCtD
Moclobemide—Syncope—Lisinopril—systemic scleroderma	0.000731	0.00183	CcSEcCtD
Moclobemide—Shock—Mycophenolic acid—systemic scleroderma	0.000727	0.00182	CcSEcCtD
Moclobemide—Hypotension—Leflunomide—systemic scleroderma	0.000724	0.00181	CcSEcCtD
Moclobemide—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000721	0.00181	CcSEcCtD
Moclobemide—Palpitations—Lisinopril—systemic scleroderma	0.00072	0.0018	CcSEcCtD
Moclobemide—Loss of consciousness—Lisinopril—systemic scleroderma	0.000717	0.0018	CcSEcCtD
Moclobemide—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000714	0.00179	CcSEcCtD
Moclobemide—Visual disturbance—Methotrexate—systemic scleroderma	0.000709	0.00178	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000706	0.00177	CcSEcCtD
Moclobemide—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000704	0.00176	CcSEcCtD
Moclobemide—Tension—Mycophenolate mofetil—systemic scleroderma	0.000701	0.00176	CcSEcCtD
Moclobemide—Insomnia—Leflunomide—systemic scleroderma	0.0007	0.00175	CcSEcCtD
Moclobemide—Abdominal distension—Prednisone—systemic scleroderma	0.0007	0.00175	CcSEcCtD
Moclobemide—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.0007	0.00175	CcSEcCtD
Moclobemide—Paraesthesia—Leflunomide—systemic scleroderma	0.000695	0.00174	CcSEcCtD
Moclobemide—Myalgia—Lisinopril—systemic scleroderma	0.000694	0.00174	CcSEcCtD
Moclobemide—Chest pain—Lisinopril—systemic scleroderma	0.000694	0.00174	CcSEcCtD
Moclobemide—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000694	0.00174	CcSEcCtD
Moclobemide—Anxiety—Lisinopril—systemic scleroderma	0.000692	0.00173	CcSEcCtD
Moclobemide—Dyspnoea—Leflunomide—systemic scleroderma	0.00069	0.00173	CcSEcCtD
Moclobemide—Hypotension—Mycophenolic acid—systemic scleroderma	0.00069	0.00173	CcSEcCtD
Moclobemide—Discomfort—Lisinopril—systemic scleroderma	0.000686	0.00172	CcSEcCtD
Moclobemide—Dyspepsia—Leflunomide—systemic scleroderma	0.000682	0.00171	CcSEcCtD
Moclobemide—Vomiting—Mometasone—systemic scleroderma	0.00068	0.0017	CcSEcCtD
Moclobemide—Dry mouth—Lisinopril—systemic scleroderma	0.000679	0.0017	CcSEcCtD
Moclobemide—Feeling abnormal—Azathioprine—systemic scleroderma	0.000676	0.00169	CcSEcCtD
Moclobemide—Rash—Mometasone—systemic scleroderma	0.000674	0.00169	CcSEcCtD
Moclobemide—Asthenia—Captopril—systemic scleroderma	0.000674	0.00169	CcSEcCtD
Moclobemide—Dermatitis—Mometasone—systemic scleroderma	0.000674	0.00169	CcSEcCtD
Moclobemide—Decreased appetite—Leflunomide—systemic scleroderma	0.000673	0.00169	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000673	0.00169	CcSEcCtD
Moclobemide—Osteoarthritis—Methotrexate—systemic scleroderma	0.000672	0.00168	CcSEcCtD
Moclobemide—Confusional state—Lisinopril—systemic scleroderma	0.000671	0.00168	CcSEcCtD
Moclobemide—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000671	0.00168	CcSEcCtD
Moclobemide—Headache—Mometasone—systemic scleroderma	0.00067	0.00168	CcSEcCtD
Moclobemide—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000669	0.00168	CcSEcCtD
Moclobemide—Insomnia—Mycophenolic acid—systemic scleroderma	0.000668	0.00167	CcSEcCtD
Moclobemide—Fatigue—Leflunomide—systemic scleroderma	0.000668	0.00167	CcSEcCtD
Moclobemide—Pruritus—Captopril—systemic scleroderma	0.000665	0.00167	CcSEcCtD
Moclobemide—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000663	0.00166	CcSEcCtD
Moclobemide—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000663	0.00166	CcSEcCtD
Moclobemide—Constipation—Leflunomide—systemic scleroderma	0.000662	0.00166	CcSEcCtD
Moclobemide—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000659	0.00165	CcSEcCtD
Moclobemide—Somnolence—Mycophenolic acid—systemic scleroderma	0.000657	0.00165	CcSEcCtD
Moclobemide—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000656	0.00164	CcSEcCtD
Moclobemide—Shock—Lisinopril—systemic scleroderma	0.000655	0.00164	CcSEcCtD
Moclobemide—CYP1A2—lung—systemic scleroderma	0.000654	0.0223	CbGeAlD
Moclobemide—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00065	0.00163	CcSEcCtD
Moclobemide—Tachycardia—Lisinopril—systemic scleroderma	0.000649	0.00163	CcSEcCtD
Moclobemide—Abdominal pain—Azathioprine—systemic scleroderma	0.000648	0.00162	CcSEcCtD
Moclobemide—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000644	0.00161	CcSEcCtD
Moclobemide—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000643	0.00161	CcSEcCtD
Moclobemide—Diarrhoea—Captopril—systemic scleroderma	0.000643	0.00161	CcSEcCtD
Moclobemide—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000642	0.00161	CcSEcCtD
Moclobemide—Irritability—Methotrexate—systemic scleroderma	0.000641	0.00161	CcSEcCtD
Moclobemide—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000641	0.0016	CcSEcCtD
Moclobemide—Feeling abnormal—Leflunomide—systemic scleroderma	0.000638	0.0016	CcSEcCtD
Moclobemide—Fatigue—Mycophenolic acid—systemic scleroderma	0.000637	0.0016	CcSEcCtD
Moclobemide—Nausea—Mometasone—systemic scleroderma	0.000635	0.00159	CcSEcCtD
Moclobemide—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000633	0.00159	CcSEcCtD
Moclobemide—Constipation—Mycophenolic acid—systemic scleroderma	0.000632	0.00158	CcSEcCtD
Moclobemide—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000631	0.00158	CcSEcCtD
Moclobemide—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000628	0.00157	CcSEcCtD
Moclobemide—Hypotension—Lisinopril—systemic scleroderma	0.000622	0.00156	CcSEcCtD
Moclobemide—Dizziness—Captopril—systemic scleroderma	0.000621	0.00156	CcSEcCtD
Moclobemide—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000617	0.00154	CcSEcCtD
Moclobemide—Urticaria—Leflunomide—systemic scleroderma	0.000615	0.00154	CcSEcCtD
Moclobemide—Abdominal pain—Leflunomide—systemic scleroderma	0.000612	0.00153	CcSEcCtD
Moclobemide—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000609	0.00152	CcSEcCtD
Moclobemide—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000608	0.00152	CcSEcCtD
Moclobemide—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000608	0.00152	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000606	0.00152	CcSEcCtD
Moclobemide—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000606	0.00152	CcSEcCtD
Moclobemide—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000604	0.00151	CcSEcCtD
Moclobemide—Insomnia—Lisinopril—systemic scleroderma	0.000602	0.00151	CcSEcCtD
Moclobemide—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000601	0.00151	CcSEcCtD
Moclobemide—Paraesthesia—Lisinopril—systemic scleroderma	0.000597	0.0015	CcSEcCtD
Moclobemide—Vomiting—Captopril—systemic scleroderma	0.000597	0.0015	CcSEcCtD
Moclobemide—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000595	0.00149	CcSEcCtD
Moclobemide—Dyspnoea—Lisinopril—systemic scleroderma	0.000593	0.00149	CcSEcCtD
Moclobemide—Rash—Captopril—systemic scleroderma	0.000592	0.00148	CcSEcCtD
Moclobemide—Dermatitis—Captopril—systemic scleroderma	0.000592	0.00148	CcSEcCtD
Moclobemide—Somnolence—Lisinopril—systemic scleroderma	0.000592	0.00148	CcSEcCtD
Moclobemide—Headache—Captopril—systemic scleroderma	0.000589	0.00147	CcSEcCtD
Moclobemide—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000588	0.00147	CcSEcCtD
Moclobemide—Dyspepsia—Lisinopril—systemic scleroderma	0.000586	0.00147	CcSEcCtD
Moclobemide—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000584	0.00146	CcSEcCtD
Moclobemide—Decreased appetite—Lisinopril—systemic scleroderma	0.000578	0.00145	CcSEcCtD
Moclobemide—Fatigue—Lisinopril—systemic scleroderma	0.000574	0.00144	CcSEcCtD
Moclobemide—Shock—Mycophenolate mofetil—systemic scleroderma	0.000574	0.00144	CcSEcCtD
Moclobemide—Constipation—Lisinopril—systemic scleroderma	0.000569	0.00143	CcSEcCtD
Moclobemide—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000569	0.00143	CcSEcCtD
Moclobemide—Bradycardia—Prednisone—systemic scleroderma	0.000566	0.00142	CcSEcCtD
Moclobemide—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000564	0.00141	CcSEcCtD
Moclobemide—Diarrhoea—Azathioprine—systemic scleroderma	0.000561	0.00141	CcSEcCtD
Moclobemide—Nausea—Captopril—systemic scleroderma	0.000558	0.0014	CcSEcCtD
Moclobemide—CYP2D6—digestive system—systemic scleroderma	0.000558	0.019	CbGeAlD
Moclobemide—Asthenia—Leflunomide—systemic scleroderma	0.000556	0.00139	CcSEcCtD
Moclobemide—Hallucination—Prednisone—systemic scleroderma	0.000553	0.00139	CcSEcCtD
Moclobemide—Feeling abnormal—Lisinopril—systemic scleroderma	0.000548	0.00137	CcSEcCtD
Moclobemide—Pruritus—Leflunomide—systemic scleroderma	0.000548	0.00137	CcSEcCtD
Moclobemide—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000545	0.00136	CcSEcCtD
Moclobemide—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000544	0.00136	CcSEcCtD
Moclobemide—Dysuria—Methotrexate—systemic scleroderma	0.000543	0.00136	CcSEcCtD
Moclobemide—Dizziness—Azathioprine—systemic scleroderma	0.000542	0.00136	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000531	0.00133	CcSEcCtD
Moclobemide—Asthenia—Mycophenolic acid—systemic scleroderma	0.00053	0.00133	CcSEcCtD
Moclobemide—Diarrhoea—Leflunomide—systemic scleroderma	0.00053	0.00133	CcSEcCtD
Moclobemide—Urticaria—Lisinopril—systemic scleroderma	0.000529	0.00132	CcSEcCtD
Moclobemide—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000527	0.00132	CcSEcCtD
Moclobemide—Abdominal pain—Lisinopril—systemic scleroderma	0.000526	0.00132	CcSEcCtD
Moclobemide—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000524	0.00131	CcSEcCtD
Moclobemide—Pruritus—Mycophenolic acid—systemic scleroderma	0.000523	0.00131	CcSEcCtD
Moclobemide—Vomiting—Azathioprine—systemic scleroderma	0.000521	0.00131	CcSEcCtD
Moclobemide—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00052	0.0013	CcSEcCtD
Moclobemide—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000518	0.0013	CcSEcCtD
Moclobemide—Drowsiness—Methotrexate—systemic scleroderma	0.000518	0.0013	CcSEcCtD
Moclobemide—Rash—Azathioprine—systemic scleroderma	0.000517	0.0013	CcSEcCtD
Moclobemide—Dermatitis—Azathioprine—systemic scleroderma	0.000517	0.00129	CcSEcCtD
Moclobemide—Flushing—Prednisone—systemic scleroderma	0.000516	0.00129	CcSEcCtD
Moclobemide—Headache—Azathioprine—systemic scleroderma	0.000514	0.00129	CcSEcCtD
Moclobemide—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000513	0.00129	CcSEcCtD
Moclobemide—Dizziness—Leflunomide—systemic scleroderma	0.000512	0.00128	CcSEcCtD
Moclobemide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000507	0.00127	CcSEcCtD
Moclobemide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000505	0.00127	CcSEcCtD
Moclobemide—Stomatitis—Methotrexate—systemic scleroderma	0.000505	0.00126	CcSEcCtD
Moclobemide—Conjunctivitis—Methotrexate—systemic scleroderma	0.000503	0.00126	CcSEcCtD
Moclobemide—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000499	0.00125	CcSEcCtD
Moclobemide—Sweating—Methotrexate—systemic scleroderma	0.000496	0.00124	CcSEcCtD
Moclobemide—Vomiting—Leflunomide—systemic scleroderma	0.000492	0.00123	CcSEcCtD
Moclobemide—Dizziness—Mycophenolic acid—systemic scleroderma	0.000489	0.00122	CcSEcCtD
Moclobemide—Rash—Leflunomide—systemic scleroderma	0.000488	0.00122	CcSEcCtD
Moclobemide—Dermatitis—Leflunomide—systemic scleroderma	0.000488	0.00122	CcSEcCtD
Moclobemide—Nausea—Azathioprine—systemic scleroderma	0.000487	0.00122	CcSEcCtD
Moclobemide—Headache—Leflunomide—systemic scleroderma	0.000485	0.00122	CcSEcCtD
Moclobemide—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00048	0.0012	CcSEcCtD
Moclobemide—Asthenia—Lisinopril—systemic scleroderma	0.000477	0.0012	CcSEcCtD
Moclobemide—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000477	0.00119	CcSEcCtD
Moclobemide—Pruritus—Lisinopril—systemic scleroderma	0.000471	0.00118	CcSEcCtD
Moclobemide—Vomiting—Mycophenolic acid—systemic scleroderma	0.00047	0.00118	CcSEcCtD
Moclobemide—Rash—Mycophenolic acid—systemic scleroderma	0.000466	0.00117	CcSEcCtD
Moclobemide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000465	0.00117	CcSEcCtD
Moclobemide—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000463	0.00116	CcSEcCtD
Moclobemide—Headache—Mycophenolic acid—systemic scleroderma	0.000463	0.00116	CcSEcCtD
Moclobemide—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000461	0.00115	CcSEcCtD
Moclobemide—Nausea—Leflunomide—systemic scleroderma	0.00046	0.00115	CcSEcCtD
Moclobemide—Vision blurred—Prednisone—systemic scleroderma	0.000456	0.00114	CcSEcCtD
Moclobemide—Diarrhoea—Lisinopril—systemic scleroderma	0.000455	0.00114	CcSEcCtD
Moclobemide—Ill-defined disorder—Prednisone—systemic scleroderma	0.000449	0.00113	CcSEcCtD
Moclobemide—Visual impairment—Methotrexate—systemic scleroderma	0.000448	0.00112	CcSEcCtD
Moclobemide—Agitation—Prednisone—systemic scleroderma	0.000445	0.00111	CcSEcCtD
Moclobemide—Dizziness—Lisinopril—systemic scleroderma	0.00044	0.0011	CcSEcCtD
Moclobemide—Nausea—Mycophenolic acid—systemic scleroderma	0.000439	0.0011	CcSEcCtD
Moclobemide—Malaise—Prednisone—systemic scleroderma	0.000437	0.00109	CcSEcCtD
Moclobemide—Syncope—Prednisone—systemic scleroderma	0.000434	0.00109	CcSEcCtD
Moclobemide—Tinnitus—Methotrexate—systemic scleroderma	0.000433	0.00109	CcSEcCtD
Moclobemide—Loss of consciousness—Prednisone—systemic scleroderma	0.000426	0.00107	CcSEcCtD
Moclobemide—Vomiting—Lisinopril—systemic scleroderma	0.000423	0.00106	CcSEcCtD
Moclobemide—Rash—Lisinopril—systemic scleroderma	0.00042	0.00105	CcSEcCtD
Moclobemide—Dermatitis—Lisinopril—systemic scleroderma	0.000419	0.00105	CcSEcCtD
Moclobemide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000418	0.00105	CcSEcCtD
Moclobemide—Hypertension—Prednisone—systemic scleroderma	0.000418	0.00105	CcSEcCtD
Moclobemide—Headache—Lisinopril—systemic scleroderma	0.000417	0.00104	CcSEcCtD
Moclobemide—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000412	0.00103	CcSEcCtD
Moclobemide—Myalgia—Prednisone—systemic scleroderma	0.000412	0.00103	CcSEcCtD
Moclobemide—Anxiety—Prednisone—systemic scleroderma	0.000411	0.00103	CcSEcCtD
Moclobemide—Discomfort—Prednisone—systemic scleroderma	0.000407	0.00102	CcSEcCtD
Moclobemide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000399	0.000999	CcSEcCtD
Moclobemide—Dysgeusia—Methotrexate—systemic scleroderma	0.000396	0.000993	CcSEcCtD
Moclobemide—Nausea—Lisinopril—systemic scleroderma	0.000395	0.00099	CcSEcCtD
Moclobemide—Shock—Prednisone—systemic scleroderma	0.000389	0.000974	CcSEcCtD
Moclobemide—Tachycardia—Prednisone—systemic scleroderma	0.000386	0.000966	CcSEcCtD
Moclobemide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000386	0.000966	CcSEcCtD
Moclobemide—Hyperhidrosis—Prednisone—systemic scleroderma	0.000382	0.000957	CcSEcCtD
Moclobemide—Vision blurred—Methotrexate—systemic scleroderma	0.000381	0.000955	CcSEcCtD
Moclobemide—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000375	0.000941	CcSEcCtD
Moclobemide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000371	0.000929	CcSEcCtD
Moclobemide—Rash—Mycophenolate mofetil—systemic scleroderma	0.000368	0.000921	CcSEcCtD
Moclobemide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000367	0.00092	CcSEcCtD
Moclobemide—Headache—Mycophenolate mofetil—systemic scleroderma	0.000365	0.000915	CcSEcCtD
Moclobemide—Malaise—Methotrexate—systemic scleroderma	0.000365	0.000914	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00036	0.000902	CcSEcCtD
Moclobemide—Insomnia—Prednisone—systemic scleroderma	0.000357	0.000895	CcSEcCtD
Moclobemide—Paraesthesia—Prednisone—systemic scleroderma	0.000355	0.000889	CcSEcCtD
Moclobemide—Dyspepsia—Prednisone—systemic scleroderma	0.000348	0.000871	CcSEcCtD
Moclobemide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000346	0.000867	CcSEcCtD
Moclobemide—Myalgia—Methotrexate—systemic scleroderma	0.000345	0.000863	CcSEcCtD
Moclobemide—Chest pain—Methotrexate—systemic scleroderma	0.000345	0.000863	CcSEcCtD
Moclobemide—Decreased appetite—Prednisone—systemic scleroderma	0.000344	0.000861	CcSEcCtD
Moclobemide—Fatigue—Prednisone—systemic scleroderma	0.000341	0.000854	CcSEcCtD
Moclobemide—Discomfort—Methotrexate—systemic scleroderma	0.00034	0.000853	CcSEcCtD
Moclobemide—Constipation—Prednisone—systemic scleroderma	0.000338	0.000847	CcSEcCtD
Moclobemide—Confusional state—Methotrexate—systemic scleroderma	0.000333	0.000834	CcSEcCtD
Moclobemide—Feeling abnormal—Prednisone—systemic scleroderma	0.000326	0.000816	CcSEcCtD
Moclobemide—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000323	0.00081	CcSEcCtD
Moclobemide—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000319	0.0008	CcSEcCtD
Moclobemide—Urticaria—Prednisone—systemic scleroderma	0.000314	0.000786	CcSEcCtD
Moclobemide—Abdominal pain—Prednisone—systemic scleroderma	0.000312	0.000783	CcSEcCtD
Moclobemide—Hypotension—Methotrexate—systemic scleroderma	0.000309	0.000773	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000301	0.000754	CcSEcCtD
Moclobemide—Insomnia—Methotrexate—systemic scleroderma	0.000299	0.000748	CcSEcCtD
Moclobemide—Paraesthesia—Methotrexate—systemic scleroderma	0.000297	0.000743	CcSEcCtD
Moclobemide—Dyspnoea—Methotrexate—systemic scleroderma	0.000294	0.000738	CcSEcCtD
Moclobemide—Somnolence—Methotrexate—systemic scleroderma	0.000294	0.000736	CcSEcCtD
Moclobemide—Dyspepsia—Methotrexate—systemic scleroderma	0.000291	0.000728	CcSEcCtD
Moclobemide—Decreased appetite—Methotrexate—systemic scleroderma	0.000287	0.000719	CcSEcCtD
Moclobemide—Fatigue—Methotrexate—systemic scleroderma	0.000285	0.000713	CcSEcCtD
Moclobemide—Asthenia—Prednisone—systemic scleroderma	0.000284	0.00071	CcSEcCtD
Moclobemide—Pruritus—Prednisone—systemic scleroderma	0.00028	0.0007	CcSEcCtD
Moclobemide—Feeling abnormal—Methotrexate—systemic scleroderma	0.000272	0.000682	CcSEcCtD
Moclobemide—Diarrhoea—Prednisone—systemic scleroderma	0.00027	0.000677	CcSEcCtD
Moclobemide—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00027	0.000677	CcSEcCtD
Moclobemide—Urticaria—Methotrexate—systemic scleroderma	0.000262	0.000657	CcSEcCtD
Moclobemide—Dizziness—Prednisone—systemic scleroderma	0.000261	0.000655	CcSEcCtD
Moclobemide—Abdominal pain—Methotrexate—systemic scleroderma	0.000261	0.000654	CcSEcCtD
Moclobemide—Vomiting—Prednisone—systemic scleroderma	0.000251	0.000629	CcSEcCtD
Moclobemide—Rash—Prednisone—systemic scleroderma	0.000249	0.000624	CcSEcCtD
Moclobemide—Dermatitis—Prednisone—systemic scleroderma	0.000249	0.000624	CcSEcCtD
Moclobemide—Headache—Prednisone—systemic scleroderma	0.000248	0.00062	CcSEcCtD
Moclobemide—Asthenia—Methotrexate—systemic scleroderma	0.000237	0.000594	CcSEcCtD
Moclobemide—Nausea—Prednisone—systemic scleroderma	0.000235	0.000588	CcSEcCtD
Moclobemide—Pruritus—Methotrexate—systemic scleroderma	0.000234	0.000585	CcSEcCtD
Moclobemide—Diarrhoea—Methotrexate—systemic scleroderma	0.000226	0.000566	CcSEcCtD
Moclobemide—Dizziness—Methotrexate—systemic scleroderma	0.000218	0.000547	CcSEcCtD
Moclobemide—Vomiting—Methotrexate—systemic scleroderma	0.00021	0.000526	CcSEcCtD
Moclobemide—Rash—Methotrexate—systemic scleroderma	0.000208	0.000522	CcSEcCtD
Moclobemide—Dermatitis—Methotrexate—systemic scleroderma	0.000208	0.000521	CcSEcCtD
Moclobemide—Headache—Methotrexate—systemic scleroderma	0.000207	0.000518	CcSEcCtD
Moclobemide—Nausea—Methotrexate—systemic scleroderma	0.000196	0.000491	CcSEcCtD
